D

DiscGenics

46 employees

Regenerative Cell Therapy for Chronic Back Pain.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Life Science

Date founded

2007

Funding rounds raised

Total raised

$50M

from 2 investors over 2 rounds

D

DiscGenics raised $50M on August 25, 2020

Investors: Eagle Venture Fund and (株)ケアネット

FAQ